VHL — Vitasora Health Share Price
- AU$49.08m
- AU$1.04m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -154.28% | ||
Return on Equity | -181.82% | ||
Operating Margin | -409.37% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 2.21 | 1.44 | 0.78 | 0.66 | 1.04 | 11.91 | n/a | 0.14% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Vitasora Health Limited, formerly Respiri Limited, is an Australia-based healthcare technology and services company that focuses on digital Connected Care in the United States healthcare market. The Company offers remote patient monitoring (RPM) and chronic care management (CCM) services. Its Care Management model enables healthcare organizations to extend care beyond their clinics, integrating multi-device remote monitoring, virtual clinical support, and artificial intelligence (AI)-powered decision-making.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 7th, 1987
- Public Since
- July 14th, 2000
- No. of Shareholders
- 2,929
- No. of Employees
- 2
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 1,326,524,480

- Address
- Suite 1, Level 9, 432 St Kilda Road,, MELBOURNE, 3004
- Web
- https://vitasorahealth.com.au/
- Phone
- +61 396539160
- Auditors
- William Buck Audit (Vic) Pty Ltd
Upcoming Events for VHL
Similar to VHL
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
As of Today at 24:01 UTC, shares in Vitasora Health are trading at . This share price information is delayed by 15 minutes.
Shares in Vitasora Health last closed at and the price had moved by +8.82% over the past 365 days. In terms of relative price strength the Vitasora Health share price has outperformed the ASX All Ordinaries Index by +4.88% over the past year.
There is no consensus recommendation for this security.
Find out moreVitasora Health does not currently pay a dividend.
Vitasora Health does not currently pay a dividend.
Vitasora Health does not currently pay a dividend.
To buy shares in Vitasora Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of , shares in Vitasora Health had a market capitalisation of AU$49.08m.
Here are the trading details for Vitasora Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: VHL
Based on an overall assessment of its quality, value and momentum Vitasora Health is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vitasora Health. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -53.01%.
As of the last closing price of , shares in Vitasora Health were trading -27.55% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vitasora Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at .
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Vitasora Health's management team is headed by:
- Marjan Mikel - CEO
- David Model - SVF
- Alastair Beard - SEC
- Nicholas Smedley - DRC
- Thomas Duthy - NED